Baqsimi

Product NDC: 0002-6145
11-digit product format: 000026145
Labeler code: 0002
Product ID: 0002-6145_f88837b4-7c0d-4200-aba0-e92561310058
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: glucagon
Dosage form: POWDER
Route: NASAL
Labeler: Eli Lilly and Company
Application: NDA210134
Marketing category: NDA
Marketing start: 2019-07-24
Marketing end: 0000-00-00
Substance: GLUCAGON
Active strength: 3 mg/1
Pharmacologic classes: Antihypoglycemic Agent [EPC],Gastrointestinal Motility Inhibitor [EPC],Increased Gluconeogenesis [PE],Increased Glycogenolysis [PE],Decreased GI Smooth Muscle Tone [PE],Decreased GI Motility [PE],Decreased Glycolysis [PE]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	0002-6145		D	Discontinued by firm	2026-08-17
excluded package	package	0002-6145	0002-6145-11	D	Discontinued by firm	2026-08-17
excluded package	package	0002-6145	0002-6145-27	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 6 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0002-6145-11	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0002-6145-27	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0002-6145-11	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0002-6145-27	`f5e01cc5f278…`	`a2eaf40c39c3…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N210134-001	BAQSIMI	GLUCAGON	3MG	POWDER / NASAL		RLD, RS	2019-07-24

Orange Book patents#

Current patent rows page 1 of 1 · 3 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N210134-001	10213487	2036-02-16	U-2604	Drug product	2019-08-23
N210134-001	12370241	2036-02-16	U-2604	Drug product	2025-11-14
N210134-001	10765602	2039-09-23		Drug product	2020-10-08

Orange Book exclusivity#

Current exclusivity rows page 1 of 1 · 1 matching rows.

Application-product, Exclusivity code, Expiration table
Application-product	Exclusivity code	Expiration
N210134-001	NPP	2028-03-17

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`b00525d2431f…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N210134-001	BAQSIMI	3MG	POWDER / NASAL	RLD, RS	2019-07-24	`cb3db0bc1861…`

Observed Orange Book patent history#

Patent history page 1 of 4 · 131 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-08-18 06:07:40	2026-07	N210134-001	10213487	2036-02-16	U-2604	Drug product	2019-08-23	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210134-001	12370241	2036-02-16	U-2604	Drug product	2025-11-14	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210134-001	10765602	2039-09-23		Drug product	2020-10-08	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N210134-001	10213487	2036-02-16	U-2604	Drug product	2019-08-23	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210134-001	12370241	2036-02-16	U-2604	Drug product	2025-11-14	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210134-001	10765602	2039-09-23		Drug product	2020-10-08	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210134-001	10213487	2036-02-16	U-2604	Drug product	2019-08-23	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210134-001	12370241	2036-02-16	U-2604	Drug product	2025-11-14	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210134-001	10765602	2039-09-23		Drug product	2020-10-08	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N210134-001	10213487	2036-02-16	U-2604	Drug product	2019-08-23	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N210134-001	10765602	2039-09-23		Drug product	2020-10-08	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N210134-001	10213487	2036-02-16	U-2604	Drug product	2019-08-23	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N210134-001	10894133	2038-01-03		Drug product	2021-02-10	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N210134-001	10765602	2039-09-23		Drug product	2020-10-08	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N210134-001	10213487	2036-02-16	U-2604	Drug product	2019-08-23	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N210134-001	10894133	2038-01-03		Drug product	2021-02-10	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N210134-001	10765602	2039-09-23		Drug product	2020-10-08	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N210134-001	10213487	2036-02-16	U-2604	Drug product	2019-08-23	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N210134-001	10894133	2038-01-03		Drug product	2021-02-10	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N210134-001	10765602	2039-09-23		Drug product	2020-10-08	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N210134-001	10213487	2036-02-16	U-2604	Drug product	2019-08-23	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N210134-001	10894133	2038-01-03		Drug product	2021-02-10	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N210134-001	10765602	2039-09-23		Drug product	2020-10-08	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N210134-001	10213487	2036-02-16	U-2604	Drug product	2019-08-23	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N210134-001	10894133	2038-01-03		Drug product	2021-02-10	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N210134-001	10765602	2039-09-23		Drug product	2020-10-08	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N210134-001	10213487	2036-02-16	U-2604	Drug product	2019-08-23	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N210134-001	10894133	2038-01-03		Drug product	2021-02-10	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N210134-001	10765602	2039-09-23		Drug product	2020-10-08	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N210134-001	10213487	2036-02-16	U-2604	Drug product	2019-08-23	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N210134-001	10894133	2038-01-03		Drug product	2021-02-10	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N210134-001	10765602	2039-09-23		Drug product	2020-10-08	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N210134-001	10213487	2036-02-16	U-2604	Drug product	2019-08-23	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N210134-001	10894133	2038-01-03		Drug product	2021-02-10	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N210134-001	10765602	2039-09-23		Drug product	2020-10-08	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N210134-001	10213487	2036-02-16	U-2604	Drug product	2019-08-23	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N210134-001	10894133	2038-01-03		Drug product	2021-02-10	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N210134-001	10765602	2039-09-23		Drug product	2020-10-08	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N210134-001	10213487	2036-02-16	U-2604	Drug product	2019-08-23	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N210134-001	10894133	2038-01-03		Drug product	2021-02-10	`1e350fbaab3a…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2026-08-18 06:07:40	2026-07	N210134-001	NPP	2028-03-17	`caaa826d4ba7…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N210134-001	NP	2022-07-24	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N210134-001	NP	2022-07-24	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N210134-001	NP	2022-07-24	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N210134-001	NP	2022-07-24	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N210134-001	NP	2022-07-24	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N210134-001	NP	2022-07-24	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N210134-001	NP	2022-07-24	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N210134-001	NP	2022-07-24	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N210134-001	NP	2022-07-24	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N210134-001	NP	2022-07-24	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N210134-001	NP	2022-07-24	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N210134-001	NP	2022-07-24	`b00525d2431f…`
2023-01-26 05:58 UTC	2023-01	N210134-001	NP	2022-07-24	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N210134-001	NP	2022-07-24	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N210134-001	NP	2022-07-24	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N210134-001	NP	2022-07-24	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N210134-001	NP	2022-07-24	`cb3db0bc1861…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N210134-001	NPP	2028-03-17	`a50c72e98297…`

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0002-6145-01	EA - Each	0002-6145	8e22158b-a2c3-4de2-aa9c-b58b33deecaf	1	2019-08-06
0002-6145-02	EA - Each	0002-6145	33b3ff3a-0063-4939-996d-18be0a29f70d	1	2019-09-05
0002-6145-11	EA - Each	0002-6145	46e9837c-1cb3-49be-8a77-2ddef33dec8f	1	2019-08-06
0002-6145-27	EA - Each	0002-6145	26e32bf9-ad83-40c3-8299-3d5f24fbf9e6	1	2019-08-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0002-6145	BAQSIMI (GLUCAGON) POWDER [ELI LILLY AND COMPANY]	7	Legacy NDC	20241213_3fdb4e92-2e19-487d-9f14-99871e9fd15a.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Baqsimi	GLUCAGON	Sportpharm LLC	32ba41fa-4158-40af-8cb2-03693c248994	2026-06-19	Warnings, Adverse reactions	Exact identifier application applno (NDA): 210134 application number: NDA210134
Baqsimi	GLUCAGON	Amphastar Pharmaceuticals, Inc.	f1f5df9b-872f-44e5-a18f-f0b68e7e9254	2025-08-06	Warnings, Adverse reactions	Exact identifier application applno (NDA): 210134 application number: NDA210134

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
76LA80IG2G	GLUCAGON	16941-32-5	GLUCAGON

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0002-6145-11	00002614511	1 TUBE in 1 CARTON (0002-6145-11) > 1 BOTTLE, UNIT-DOSE in 1 TUBE (0002-6145-02) > 1 POWDER in 1 BOTTLE, UNIT-DOSE (0002-6145-01)	1 tube	2019-08-06	0000-00-00	No	No	Current
0002-6145-27	00002614527	2 TUBE in 1 CARTON (0002-6145-27) > 1 BOTTLE, UNIT-DOSE in 1 TUBE (0002-6145-02) > 1 POWDER in 1 BOTTLE, UNIT-DOSE (0002-6145-01)	2 tube	2019-08-06	0000-00-00	No	No	Current